Valmie Resources (VMRI), a U.S. company actively pursuing opportunities for the commercialization of cutting edge products, such as drones, in the rapidly expanding technology industry, has all the makings of a pump and dump. We received our first promotional newsletter […]
The most important takeaway from Superior Uniform Group Inc. (NASDAQ:SGC) strong operating performance for the year ended December 31, 2014 is its organic growth (18.2%) that contributed around $28 million of the year over year revenue increase of 29.5%. The balance […]
The GeoTeam has uncovered yet another opportunity with Superior Uniform Group that we feel has been overlooked by the general investing public. We have a simple and concise thesis on our newest GeoBargain, Superior Uniform Group (SGC). We disclosed our […]
GeoBargain Superior Uniform (NASDAQ:SGC) manufactures and sells a range of uniforms, image apparel, and accessories primarily in the United States. The company operates through two segments, Uniforms and Related Products, and Remote Staffing Solutions. We love SGC. The industry dynamics […]
Ocean-Bio Chem (OBCI) is another information arbitrage opportunity we’ve found. Buried in the commentary of thecompany’s video interview cited in its press release today, we found some extremely bullish notes that we want to inform our members of before the […]
Lakeland Industries (LAKE) – Short position Established LAKE (16.98; marked down to $15.00 pre market)– Recall, on 10/10/2014 we mentioned we sold our entire position in LAKE. “We first coded LAKE as a GeoSpecial on 2/6/2012 at $10.16 as a possible buyout […]
GeoTeam Waiting on Firstime Design Ltd (OOTC:FTDL) New Growth Plan to Bear Fruit Our initial optimism and reasons for coding of FTDL as a GeoBargain were based on the company rebounding from its restructuring process with a new growth model […]
Repro-Med Systems (OOTC:REPR) ($0.27) – ThisGeoBargain on the radar REPR engages in the design, manufacture, and marketing of proprietary medical devices primarily for emergency medical applications and ambulatory infusion therapy worldwide. Reported Q2 2014 results. REPR reported $2.5 million and […]